The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Clusters of Autoimmune Liver Disease Suggest Environmental Trigger

Clusters of Autoimmune Liver Disease Suggest Environmental Trigger

April 17, 2019 • By Reuters Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—A large population-based study from the U.K. provides more evidence that some autoimmune liver diseases may be triggered by exposure to something in the environment.

You Might Also Like
  • Environmental Factors in Pediatric Systemic Autoimmune Diseases
  • Psoriasis Tied to Higher Risk of Serious Liver Disease
  • Studies Find More Evidence the Microbiome Affects Autoimmune Disease

The study found a significant clustering of cases of primary biliary cholangitis (PBC), autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) in well-defined regions of north-east England and North Cumbria, suggesting an environmental agent(s) may have been involved, the researchers say.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Jessica Dyson and colleagues from Newcastle University and Newcastle upon Tyne Hospitals NHS Foundation Trust and colleagues reported their findings April 10 at The International Liver Congress in Vienna, Austria.

PBC, AIH and PSC are relatively rare and the underlying cause of these autoimmune liver diseases is not completely understood, although an interplay between genetic and environmental factors has been proposed.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Clusters of PBC have been previously reported near toxic waste sites near New York City, as well as in Northern England, but less is known about disease clusters for AIH and PSC.1

To investigate, Dr. Dyson and colleagues identified a large group of people from north-east England and North Cumbria who had PBC (n=2,150), AIH (n=963) or PSC (n=472). They used spatial point analyses to gauge disease clustering using postal addresses, and spatio-temporal analyses for those with a known year of diagnosis.

“Significant spatial clustering” was observed for all three diseases at roughly 1 to 2 km, they report in their meeting abstract. Further clustering was observed for AIH and PSC with a peak distance of roughly 10 km. Clustering was also evident at 7.5 km for PBC and was sustained to the limits of the spatial range (20 km).

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

No significant temporal clustering was found in any of the diseases, which discounts the theory of more transient environmental components such as infection may be associated with development of these diseases, the researchers note.

“This study suggests that exposure to a persistent, low-level environmental agent may have played a role in the pathogenesis of all three autoimmune liver diseases studied, not just PBC,” Dr. Dyson says in a statement from the conference.

“The varying distances of peak clustering,” she adds, “raises the possibility that different environmental factors contribute to PBC, AIH, and PSC. In previous PBC clustering studies, water reservoirs, industrial or coal mining factors, or waste disposal site toxins have been implicated. Further work is ongoing to try to identify factors that may potentially be associated with the clustering observed in our study.”

Pages: 1 2 | Single Page

Filed Under: Conditions Tagged With: autoimmune hepatitis, environment, environmental factor, liver, primary sclerosing cholangitis

You Might Also Like:
  • Environmental Factors in Pediatric Systemic Autoimmune Diseases
  • Psoriasis Tied to Higher Risk of Serious Liver Disease
  • Studies Find More Evidence the Microbiome Affects Autoimmune Disease
  • Atmospheric & Environmental Changes Tied to Organ-Specific Lupus Flares

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)